Neogen Price to Book Ratio 2010-2025 | NEOG
Historical price to book ratio values for Neogen (NEOG) over the last 10 years. The current price to book ratio for Neogen as of July 07, 2025 is 0.41.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Neogen Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-07-08 | 5.24 | 0.43 | |
| 2025-02-28 | 10.05 | $12.26 | 0.82 |
| 2024-11-30 | 14.18 | $12.30 | 1.15 |
| 2024-08-31 | 17.25 | $14.47 | 1.19 |
| 2024-05-31 | 13.15 | $14.52 | 0.91 |
| 2024-02-29 | 17.19 | $14.52 | 1.18 |
| 2023-11-30 | 16.97 | $14.54 | 1.17 |
| 2023-08-31 | 23.12 | $14.54 | 1.59 |
| 2023-05-31 | 17.49 | $14.49 | 1.21 |
| 2023-02-28 | 17.69 | $14.46 | 1.22 |
| 2022-11-30 | 16.56 | $14.37 | 1.15 |
| 2022-08-31 | 20.90 | $8.20 | 2.55 |
| 2022-05-31 | 26.46 | $8.23 | 3.21 |
| 2022-02-28 | 35.70 | $8.12 | 4.40 |
| 2021-11-30 | 40.13 | $8.03 | 5.00 |
| 2021-08-31 | 43.78 | $7.96 | 5.50 |
| 2021-05-31 | 46.16 | $7.82 | 5.90 |
| 2021-02-28 | 40.96 | $7.55 | 5.43 |
| 2020-11-30 | 37.11 | $7.30 | 5.08 |
| 2020-08-31 | 38.10 | $7.08 | 5.38 |
| 2020-05-31 | 35.61 | $6.85 | 5.20 |
| 2020-02-29 | 30.38 | $6.73 | 4.52 |
| 2019-11-30 | 33.29 | $6.55 | 5.08 |
| 2019-08-31 | 35.26 | $6.30 | 5.60 |
| 2019-05-31 | 28.18 | $6.11 | 4.61 |
| 2019-02-28 | 30.98 | $5.95 | 5.21 |
| 2018-11-30 | 32.43 | $5.78 | 5.61 |
| 2018-08-31 | 46.72 | $5.59 | 8.35 |
| 2018-05-31 | 37.86 | $5.41 | 6.99 |
| 2018-02-28 | 29.14 | $5.25 | 5.55 |
| 2017-11-30 | 31.46 | $5.05 | 6.23 |
| 2017-08-31 | 25.84 | $4.78 | 5.41 |
| 2017-05-31 | 23.73 | $4.63 | 5.12 |
| 2017-02-28 | 24.32 | $4.44 | 5.47 |
| 2016-11-30 | 23.73 | $4.29 | 5.53 |
| 2016-08-31 | 22.15 | $4.15 | 5.34 |
| 2016-05-31 | 18.51 | $4.03 | 4.59 |
| 2016-02-29 | 18.47 | $3.88 | 4.76 |
| 2015-11-30 | 22.15 | $3.78 | 5.85 |
| 2015-08-31 | 19.36 | $3.67 | 5.27 |
| 2015-05-31 | 17.53 | $3.54 | 4.94 |
| 2015-02-28 | 19.18 | $3.41 | 5.63 |
| 2014-11-30 | 16.62 | $3.32 | 5.01 |
| 2014-08-31 | 15.79 | $3.24 | 4.88 |
| 2014-05-31 | 14.17 | $3.13 | 4.53 |
| 2014-02-28 | 16.24 | $2.98 | 5.45 |
| 2013-11-30 | 19.08 | $2.89 | 6.61 |
| 2013-08-31 | 13.52 | $2.79 | 4.84 |
| 2013-05-31 | 13.62 | $2.68 | 5.07 |
| 2013-02-28 | 11.70 | $2.57 | 4.56 |
| 2012-11-30 | 11.39 | $2.49 | 4.57 |
| 2012-08-31 | 9.76 | $2.41 | 4.05 |
| 2012-05-31 | 9.73 | $2.32 | 4.20 |
| 2012-02-29 | 8.67 | $2.23 | 3.89 |
| 2011-11-30 | 8.81 | $2.16 | 4.08 |
| 2011-08-31 | 8.68 | $2.10 | 4.13 |
| 2011-05-31 | 11.21 | $2.03 | 5.53 |
| 2011-02-28 | 9.35 | $1.92 | 4.86 |
| 2010-11-30 | 9.29 | $1.86 | 4.99 |
| 2010-08-31 | 7.30 | $1.77 | 4.13 |
| 2010-05-31 | 6.43 | $1.69 | 3.80 |
| 2010-02-28 | 6.06 | $1.62 | 3.73 |
| 2009-11-30 | 5.42 | $1.57 | 3.44 |
| 2009-08-31 | 4.67 | $1.51 | 3.08 |
| 2009-05-31 | 3.67 | $1.46 | 2.52 |
| 2009-02-28 | 3.54 | $1.41 | 2.51 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.081B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.616B | 27.97 |
| Boston Scientific (BSX) | United States | $153.611B | 38.46 |
| Stryker (SYK) | United States | $149.817B | 31.33 |
| EssilorLuxottica (ESLOY) | France | $128.259B | 0.00 |
| Medtronic (MDT) | Ireland | $112.441B | 15.94 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.320B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.596B | 26.03 |
| ResMed (RMD) | United States | $37.597B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.163B | 16.22 |
| Agilent Technologies (A) | United States | $33.875B | 22.08 |
| Terumo (TRUMY) | Japan | $24.770B | 32.17 |
| Koninklijke Philips (PHG) | Netherlands | $22.956B | 16.11 |
| Insulet (PODD) | United States | $21.162B | 83.07 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.315B | 11.76 |
| Baxter (BAX) | United States | $15.236B | 11.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.113B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.723B | 23.40 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $3.900B | 17.42 |
| Perrigo (PRGO) | Ireland | $3.676B | 9.32 |
| Haemonetics (HAE) | United States | $3.609B | 16.44 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.192B | 23.54 |
| QuidelOrtho (QDEL) | United States | $1.976B | 13.59 |
| LeMaitre Vascular (LMAT) | United States | $1.875B | 41.91 |
| AtriCure (ATRC) | United States | $1.561B | 0.00 |
| Acuren (TIC) | United States | $1.375B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
| Phibro Animal Health (PAHC) | United States | $1.212B | 15.49 |
| Green Thumb Industries (GTBIF) | United States | $1.163B | 26.16 |
| BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
| InMode (INMD) | Israel | $0.954B | 9.62 |
| Kestra Medical Technologies (KMTS) | United States | $0.757B | 0.00 |
| Owens & Minor (OMI) | United States | $0.669B | 5.55 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
| CeriBell (CBLL) | United States | $0.622B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.507B | 0.00 |
| Valneva SE (VALN) | France | $0.488B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Surmodics (SRDX) | United States | $0.424B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.344B | 12.67 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| Quanterix (QTRX) | United States | $0.315B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| ZimVie (ZIMV) | United States | $0.263B | 11.94 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Brainsway (BWAY) | Israel | $0.253B | 66.85 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 73.83 |
| Cresco Labs (CRLBF) | United States | $0.247B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.186B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.13 |
| Omeros (OMER) | United States | $0.180B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 15.90 |
| Apyx Medical (APYX) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.37 |
| Jin Medical (ZJYL) | China | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.070B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.29 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Safety Shot (SHOT) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.10 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |